Literature DB >> 18190288

Pathogenesis of HIV disease: opportunities for new prevention interventions.

Anthony S Fauci1.   

Abstract

Current efforts to prevent human immunodeficiency virus (HIV) disease, which largely focus on altering human behavior, have had some notable successes yet have failed to halt the spread of the acquired immunodeficiency syndrome pandemic. A greater understanding of the pathogenesis of HIV disease is providing us with the scientific rationale for additional approaches to prevention. Some of the approaches discussed in this article are available now. For example, we have the means to screen for and treat other sexually transmitted diseases that increase vulnerability to HIV, adult male circumcision is readily available in most properly equipped hospitals, and antiretroviral agents that decrease the viral load help prevent transmission from pregnant women to their infants. Other approaches discussed are under investigation. For instance, numerous topical microbicides are in various stages of development, incremental progress is being made toward creation of an HIV vaccine designed to prevent HIV transmission or slow the course of disease in people who become infected, and studies are under way to evaluate the risks and benefits of prophylactic antiretroviral therapy in individuals at high risk for HIV disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18190288     DOI: 10.1086/522540

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  How physicians test: clinical practice guidelines and HIV screening practices with adolescent patients.

Authors:  Lori Leonard; Kathryn Berndtson; Pamela Matson; Morgan Philbin; Renata Arrington-Sanders; Jonathan M Ellen
Journal:  AIDS Educ Prev       Date:  2010-12

2.  Liposomes for HIV prophylaxis.

Authors:  Nikita K Malavia; David Zurakowski; Avi Schroeder; Amy M Princiotto; Anna R Laury; Hila E Barash; Joseph Sodroski; Robert Langer; Navid Madani; Daniel S Kohane
Journal:  Biomaterials       Date:  2011-09-08       Impact factor: 12.479

3.  Initial commitment to pre-exposure prophylaxis and circumcision for HIV prevention amongst Indian truck drivers.

Authors:  John A Schneider; Rakhi Dandona; Shravani Pasupneti; Vemu Lakshmi; Chuanhong Liao; Vijay Yeldandi; Kenneth H Mayer
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

4.  CCR5: From Natural Resistance to a New Anti-HIV Strategy.

Authors:  Lucia Lopalco
Journal:  Viruses       Date:  2010-02-05       Impact factor: 5.818

Review 5.  Natural anti-CCR5 antibodies in HIV-infection and -exposure.

Authors:  Lucia Lopalco
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

6.  Longitudinal Changes in Cd4+, Cd8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with Cryptococcal Meningitis.

Authors:  Alice Bayiyana; Samuel Okurut; Rose Nabatanzi; Godfrey Zziwa; David R Boulware; Fredrick Lutwama; David Meya
Journal:  J Fungi (Basel)       Date:  2019-07-17

7.  HIV-1 clade D is associated with increased rates of CD4 decline in a Kenyan cohort.

Authors:  Lyle R McKinnon; Nico J Nagelkerke; Rupert Kaul; Souradet Y Shaw; Rupert Capina; Ma Luo; Anthony Kariri; Winnie Apidi; Makobu Kimani; Charles Wachihi; Walter Jaoko; A Omu Anzala; Joshua Kimani; T Blake Ball; Francis A Plummer
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  Spectrum of false positivity for the fourth generation human immunodeficiency virus diagnostic tests.

Authors:  Peter Liu; Patrick Jackson; Nathan Shaw; Scott Heysell
Journal:  AIDS Res Ther       Date:  2016-01-05       Impact factor: 2.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.